Raymond James downgraded Apellis Pharmaceuticals (NASDAQ:APLS) to Outperform from Strong Buy following a first-quarter sales miss and rising concerns over volatility in the company’s revenue outlook.

Thank you for standing by and welcome to the Rocket Companies first quarter 2025 earnings conference call. (Operator Instructions) Thank you. I'd now like to turn the call over to Sharon Ng, Head of ...

A 2023 paper by researchers from Anthropic found that it was a “general behavior of state-of-the-art AI assistants,” and that large language models sometimes sacrifice “truthfulness” to align with a ...

In the May 20 primary, most borough voters will see contested races on at least one party’s ballot. Carlisle With Carlisle ...

Discover the Best Kratom Strains and Products for Natural Energy, Focus, and Motivation — Featuring Super Speciosa’s Clean, ...

“We’re a throwback to an older model that sees serious engagement with the great debates of the Western tradition as the best possible preparation for leadership,” said Antonio Sosa, a professor at UT ...